vs. current intensity before and after bath application of 30 nM MgTx (not significant differences were found for interaction or genotype, significant current intensity effect in B, p<0.0001, two way RM ANOVA n=3 cells from 3 juvenile mice). (D) Average instantaneous firing frequency of SCINs vs interspike interval (ISI) in response to 1-s, 140 pA depolarization for SCINs before and after bath application of 30 nM MgTx (not significantly different, non-linear regression using an exponential decay model, p=0.138, n=6 cells from 4 juvenile mice). (E) Representative responses of an accommodating SCIN to 1-s, 140 pA depolarization pulse before (left) and after (right) bath application of 10 nM ADWX-1. (F-G) Average firing frequency (F) and last spike-time (G) in response to 1-s, 140 pA depolarization pulse before and after bath application of 0.1, 1 and 10 nM ADWX-1 (two way RM ANOVA, interaction: p<0.05, *p<0.05 pos hoc test, n=4 cells from 3 juvenile mice in each group). (H) Representative responses of an accommodating SCIN to 1-s, 140 pA depolarization pulse before (left) and after (right) bath application of 30 nM AgTx-2. (I-J) Average firing frequency (I) and last spike-time (J) vs. current intensity before and after bath application of 30 nM AgTx-2 (two way RM ANOVA interaction: **p<0.0001, main treatment effect: *p=0.0256, 4 cells from 2 juvenile mice). (K) Representative recording of an accommodating SCIN before and after adding 100nM α-DTX. (L-M) Firing frequency (L) and last spike-time (M) vs. current intensity before and after α-DTX (two-way RM ANOVA, interaction: **p=0.006, main treatment effect: *p=0.03, 6 cells from 5 juvenile mice). (Rossi et al., 2011) and Rosa-CAG-LSL-tdTomato-WPRE mice (B6.CgGt(ROSA)26Sor tm14(CAG-tdTomato)Hze /J, stock 7914,The Jackson Laboratories (Madisen et al., 2010) . Juvenile and adult mice were 15-45 and 60-180 days old, respectively. Up to six mice were housed per cage with water and food ad libitum and 12:12 h light/dark cycle (lights on at 7:00 A.M.) and cared for in accordance with institutional (IACUC of the School of Medicine, University of Buenos Aires, 2598/13). Kv1.3 KO mice and controls from the same colony (4-8 weeks old) were obtained from Jackson Laboratories (B6;129S1-Kcna3tm1Lys/J) and used following experimental procedures approved by the Rosalind Franklin University of Medicine and Science Institutional Animal Care and Use Committee and guidelines from the National Institutes of Health for the care and use of laboratory animals.
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Lesion. Under deep surgical anesthesia (isofluorane, 4% in O 2 for induction, 0.5-1% for maintenance) each mouse was mounted in a stereotaxic frame (Kopf Instruments; USA). The neurotoxin 6-hydroxydopamineHBr (6-OHDA; Sigma Aldrich AB) was dissolved in 0.1% ascorbate-saline at the concentration 4µg/µl (freebase). Adult mice (70-110 days old) received 1µl injection into the left medial forebrain bundle (MFB) at the following coordinates from Bregma: 1 mm posterior, 1.1 mm lateral and 4.8 mm ventral from dura (Paxinos and Franklin 2001). Injections were performed at a rate of 0.5 µl/min using a 300 µm diameter cannula attached to a 25 µl Hamilton syringe controlled by a motorized pump (Bioanalytical Systems, USA). The injection cannula was left in place for six additional minutes before slowly retracting it. Littermates of lesioned mice received an injection of 0.1% ascorbate-saline in the MFB (sham group). After surgery, each mouse was daily weighted and received a subcutaneous injection of saline and an enriched diet. These cares continued until animals began to regain weight (7 to 20 days after surgery). To assess behavioral signs of parkinsonism, the animals were subjected to extensive behavioral testing three weeks after 6-OHDA injection in three non-consecutive days, during the light phase, by an investigator blind to treatment, as described in Escande et al. (2016) . Briefly, spontaneous ipsilateral rotation in a novel open field (40 x 40 cm) is assessed by using an automated video-tracking system (Anymaze). A rotation asymmetry index is computed by expressing the number of ipsilateral rotations relative to the total number of rotations. In the "cylinder test", each mouse is placed in a transparent acrylic cylinder (10 cm diameter and 14 cm high) and videotaped for three minutes. A limb use asymmetry score is computed by expressing the number of wall contacts performed with the forepaw contralateral to the lesion relative to the total number of wall contacts performed with the forepaws. Finally, motor coordination is assessed in an accelerating rotarod (from 4 to 40 rpm in three minutes; Ugo Basile, Italy). The latency to fall from the rod is automatically recorded with a cut-off time of three minutes. Each animal was assessed over five trials with five minutes intertrial intervals in a single day.
ChR2-YFP lentviral vector injection.
Anesthesia and surgical procedures were as indicated for the nigrostriatal lesions. A ChR2-YFP expressing lentivirus (Boyden et al., 2005) pseudotyped with the vesicular stomatitis virus glycoprotein (Kobayashi et al., 2016) was injected in the left thalamus at the following coordinates from Bregma: -1.3 mm posterior, 0.8 mm lateral and -3 mm ventral from dura (Paxinos and Franklin 2001) . Injections were performed at a rate of 0.5 µl/min using a 300 µm diameter cannula attached to a 25 µl Hamilton syringe controlled by a motorized pump (Bioanalytical Systems, USA).
Acute slicing. Mice were anesthetized with chloral hydrate (600 mg/kg, i.p.) and decapitated. The brain was quickly removed, chilled in ice-cold low Ca 2+ -high Mg 2+ ACSF and prepared for slicing. Three hundred-µm-thick coronal slices at the level of the striatum were cut by using a vibratome (Pelco T series 1000, Ted Pella). Slices were submerged in low Ca 2+ -high Mg 2+ ACSF at 34ºC for 30 min and then kept in the same ACSF at room temperature in a recovery chamber. ACSF composition was as follows (in mM): 125 NaCl, 2.5 KCl, 1.3NaH 2 PO 4 ·H 2 O, 26 NaHCO 3 , 2 CaCl 2 , 1 MgCl 2 , and 10 glucose. For low-Ca 2+-high-Mg 2+ ACSF, 0.5 mM CaCl 2 and 2.5 mM MgCl 2 were used.
Electrophysiological recordings. Slices were transferred to a submersion type chamber perfused by a peristaltic pump (Ismatec, Germany) with ACSF at a constant rate of 3 ml/min; temperature in the recording chamber was set at 34ºC with a TC-344B temperature controller (Warner Instruments). Cells were visualized using an upright microscope (Nikon Eclipse) equipped with a 40X water-immersion objective, DIC and fluorescent optics, and an infrared camera connected to a monitor and computer. Recording electrodes were made with borosilicate glass capillaries shaped with a puller (P-97, Sutter Instruments). For whole-cell recordings, electrodes were filled with internal solution containing the following (in mM): 20 KCl, 120 K-gluconate, 10 HEPES, 3 Na 2 ATP, 0.3 NaGTP, 0.1 EGTA, 10 phosphocreatine and 2 MgCl 2 , pH 7.3 adjusted with KOH. Neurobiotin was included in the intracellular solution for Kv1.3 KO recordings. Recordings were amplified (Axopatch-1D; Molecular Devices, or Multiclamp 700B for Kv1.3 KO recordings), sampled at 20 kHz (Digidata 1322A, Molecular Devices) and acquired on a PC running pClamp 9.2 (Molecular Devices). Cells considered for data analysis fulfilled the following criteria: series resistance between 10 and 30 MΩ, action potential amplitude >50 mV from threshold to peak and resting membrane potential between -75 and -45 mV. For recordings in voltage-clamp mode, capacitance and series resistance compensation (at least 60%) were used to minimize voltage errors. Settings were determined by compensating the transients of a small (10 mV), 50-ms hyperpolarizing voltage step. Leak conductance was not subtracted. The liquid junction potential was not compensated. Drugs applied through the recording pipette included RGS4 (P0878G,GenwayBiotech, San Diego, CA), CCG 63802 (4028/10, R&D Systems, Minneapolis MN) and anti-Kv1.3 intracellular domain (L23/27, Neuromab).
Pharmacological manipulations. Unless otherwise stated, reagents were purchased from Sigma (Argentina). Drugs were prepared as stock solutions, diluted in ACSF immediately before use and applied through the perfusion system. The following stock solvents and final concentrations were used: destilled H 2 O for CdCl 2 ·H 2 O (200 µM), SCH 23390 (1 µM), ZD 7288 (30 µM), ADWX-1 (Alomone Labs, 0.1, 1 and 1 nM) and tetrodotoxin (TTX, Alomone Labs, 1 µM); DMSO for CNQX (50 µM), XE 991 (10 µM), picrotoxin (100 µM) and sulpiride (Santa Cruz Biotechnology, 10 µM); the manufacturer's recommended storage buffer (0.1% BSA, 100mM NaCl, 10 mM Tris pH 7.5, 1 mM EDTA) for Tytiustoxin, Agitoxin-2, α-Dendrotoxin and Margatoxin (TsTx, AgTx-2, α-DTX and MgTx, Alomone Labs, 100 nM, 30 nM, 100 nM and 30 nM, respectively).
Acquisition and analysis of electrophysiological data. Data acquisition and analysis were performed with ClampFit (Molecular Devices). GraphPad Prism version 6.00 for Windows (GraphPad Software) was used for data analysis. Normality and homocedasticity were evaluated with SigmaPlot 11.0. SCIN classification by unsupervised multivariate clustering analysis was based on two variables that, after exploratory data analysis, robustly separated accommodating from non-accommodating SCINs (last spike-time and number of spikes fired during a 1-sec, 140 pA step depolarization). Additionally, SCIN classification was performed with three variables: last spike-time, number of spikes fired and rheobase, since rheobase emerged as a an important variable in principal component analysis (PCA). This analysis suggested that accommodating SCINs may be subdivided in two clusters, one with high and another with low rheobase (Figures S2 and S7 ). The MgTx-sensitive conductance was calculated as G MgTx = I MgTx / (Vm-E K ), where I MgTx is the MgTx-sensitive current elicited by a voltage ramp (-100 mV to +40 mV, slope 33 mV/sec), Vm is the voltage command and E K is the estimated reversal potential for K + in our conditions (E K = -107 mV). Resting membrane potential was measured at the baseline before the injection of current pulses, and the input resistance was calculated as ∆V/∆I in response to a 1-sec, -10 pA current pulse. Sag amplitude was measured as the difference between the peak hyperpolarization and the steady-state elicited by the 1-sec current pulse of -40 pA. sAHP amplitude was measured as the difference between the peak hyperpolarization elicited after the end of the current pulse of 140 pA and the membrane potential just before the current step (baseline). Rheobase was calculated as the minimal amplitude of a current step that resulted in the firing of at least one spike. Action potential threshold was obtained from action potential phase plots as the point at which the derivate of the membrane potential dV/dt deviated from the mean baseline value by >2 standard deviations (Atherton and Bevan, 2005) . The width of the action potential was calculated at 50% of the maximal amplitude, which was measured from threshold to peak. Threshold, width and amplitude were measured only for the first spike elicited at rheobase .
Immunohistochemistry.Immunostaining was performed in paraformaldehyde-fixed free-floating sections as previously reported (Braz et al., 2015) . For tyrosine hydroxylase (TH) immunolabeling in 6-OHDA-and sham-lesioned animals, the brainstem was fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB), cryoprotected in 30% sucrose/PB and cut at 40 µm using a sliding-freezing microtome (Leica SM 2010R). For all other markers, ChATCre;tdT mice were anesthetized with chloral hydrate (600 mg/kg, i.p.), perfused through the ascending aorta with saline solution supplemented with heparin (10 U/ml, Rivero, Argentina) followed by 4% paraformaldehyde in PB. Brains were removed, post-fixed for 2 hr in the same fixative, cryoprotected in 30% sucrose/PB and cut. Sections containing the striatum and the substantia nigra were preserved in phosphate buffered saline 0.1 M, pH 7.4 (PBS) with 0.1% sodium azide. Sections were blocked for 2 hr at room temperature, incubated overnight with primary antibodies at 4ºC, washed 3 times in PBS and incubated with secondary antibodies conjugated to Alexa Fluor dyes (Invitrogen) or biotin (Vector Laboratories). In the latter case sections were washed 3 times for 10 min in PBS and then incubated with FITC-streptavidin (Vector) according to the conditions indicated in the following Table. Sections were then washed in PBS, mounted on glass slides with Vectashield (Vector) and coverslipped.
Image acquisition and analysis. Images were acquired with an Olympus FV1000/IX81 confocal microscope as single sections, using an oil-immersion objective (40X; numerical aperture, 1.3). Digital images were color balanced with Adobe Photoshop 8.0 (Adobe Systems). The composition of the images was not altered. To quantify Kv1.3 immunoreactivity in SCINs, SCINs were detected by an automated method applied to the tdTomato channel (Otsu thresholding and particle analysis, Image J) (Schneider et al., 2012) and average intensity of the Kv1.3 label was quantified in the detected particles. The average intensity value of each particle was background subtracted using the average intensity of an adjacent region of neuropil of comparable size. The same method was used to determine the percentage of PV-, NOS1-and NPY-positive SCINs, which were considered positive when the immunofluorescence for these markers was >2 SD above mean background fluorescence.
